NasdaqCM - Nasdaq Real Time Price USD
Aldeyra Therapeutics, Inc. (ALDX)
2.1800
+0.0200
+(0.93%)
At close: May 9 at 4:00:01 PM EDT
2.2200
+0.04
+(1.83%)
After hours: May 9 at 5:12:39 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.87M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
PERCEPTIVE ADVISORS L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.42 per share. | Indirect | 4,828,000 | Apr 3, 2025 |
MACHATHA STEPHEN Officer | Sale at price 4.74 per share. | Direct | 75,975 | Aug 12, 2024 |
GREENBERG BRUCE Chief Financial Officer | Sale at price 4.74 per share. | Direct | 51,313 | Aug 12, 2024 |
PERCEPTIVE ADVISORS L L C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.67 - 4.74 per share. | Indirect | 833,867 | Apr 5, 2024 |
PERCEPTIVE ADVISORS L L C Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.25 - 4.09 per share. | Indirect | 1,934,505 | Apr 3, 2024 |
BRADY TODD C Chief Executive Officer | Sale at price 3.05 - 3.27 per share. | Direct | 580,760 | Mar 12, 2024 |
MACHATHA STEPHEN Officer | Sale at price 3.16 - 3.41 per share. | Direct | 98,605 | Mar 12, 2024 |
GREENBERG BRUCE Chief Financial Officer | Sale at price 3.41 per share. | Direct | 44,968 | Mar 11, 2024 |
GREENBERG BRUCE Chief Financial Officer | Sale at price 3.41 per share. | Direct | 44,968 | Mar 11, 2024 |
PERCEPTIVE ADVISORS L L C Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.60 - 1.74 per share. | Indirect | 4,453,308 | Oct 18, 2023 |
PHILLIPS GARY M Director | Conversion of Exercise of derivative security at price 0.55 per share. | Direct | 3,001 | Sep 7, 2023 |
BRADY TODD C Chief Executive Officer | Conversion of Exercise of derivative security at price 0.55 per share. | Direct | 150,728 | Sep 7, 2023 |
WALKER NEAL Director | Conversion of Exercise of derivative security at price 0.55 per share. | Direct | 5,301 | Aug 22, 2023 |
BRONSTEIN BEN Director | Conversion of Exercise of derivative security at price 0.55 per share. | Direct | 5,301 | Jun 27, 2023 |
Related Tickers
ABEO Abeona Therapeutics Inc.
5.27
-4.01%
CAPR Capricor Therapeutics, Inc.
6.34
-9.04%
ARDX Ardelyx, Inc.
3.6200
-0.55%
MIST Milestone Pharmaceuticals Inc.
1.1100
-7.50%
ATRA Atara Biotherapeutics, Inc.
7.27
-2.02%
VOR Vor Biopharma Inc.
0.1513
-5.44%
APLS Apellis Pharmaceuticals, Inc.
17.30
-2.86%
REPL Replimune Group, Inc.
7.71
-0.77%
CYTK Cytokinetics, Incorporated
31.70
-2.42%
CRVS Corvus Pharmaceuticals, Inc.
4.4300
+32.24%